Trial document




drksid header

  DRKS00003561

Trial Description

start of 1:1-Block title

Title

Study to evaluate the therapy of pigmented purpura progressiva with rutin and vitamin c - a retrospective study

end of 1:1-Block title
start of 1:1-Block acronym

Trial Acronym

CiPPP

end of 1:1-Block acronym
start of 1:1-Block url

URL of the Trial

http://www.umm.de

end of 1:1-Block url
start of 1:1-Block public summary

Brief Summary in Lay Language

This is a retrospective study to evaluate the efficacy of Rutin and Vitamin C in the treatment of Purpura Pigmentosa Progressiva (PPP). All patients (>6 age) with the diagnosis of PPP that were treated with rutin and vitamin c will be asked by a phone interview about the therapeutical success. Patients will be questioned wether a therapy with rutin and vitamin c did improve their disease of PPP. Moreover side-effects will be documented.

end of 1:1-Block public summary
start of 1:1-Block scientific synopsis

Brief Summary in Scientific Language

to receive new informations on pathomechanism and therapy efficacy on PPP

end of 1:1-Block scientific synopsis
start of 1:1-Block organizational data

Organizational Data

  •   DRKS00003561
  •   2012/02/29
  •   [---]*
  •   yes
  •   Approved
  •   2012-217N-MA, Medizinische Ethik-Kommission II Medizinische Fakultät Mannheim der Universität Heidelberg
end of 1:1-Block organizational data
start of 1:n-Block secondary IDs

Secondary IDs

  • [---]*
end of 1:n-Block secondary IDs
start of 1:N-Block indications

Health Condition or Problem studied

  •   Purpura Pigmentosa Progressiva
  •   Morbus Schamberg L81.7
  •   L81.7 -  Pigmented purpuric dermatosis
end of 1:N-Block indications
start of 1:N-Block interventions

Interventions/Observational Groups

  •   Patients suffering from purpura pigmentosa progressiva will be asked about their therapeutically outcome upon the treatment with rutin and vitamin c
end of 1:N-Block interventions
start of 1:1-Block design

Characteristics

  •   Non-interventional
  •   Observational study
  •   Single arm study
  •   Open (masking not used)
  •   [---]*
  •   Uncontrolled/Single arm
  •   Treatment
  •   Single (group)
  •   N/A
  •   N/A
end of 1:1-Block design
start of 1:1-Block primary endpoint

Primary Outcome

therapy efficacy by use of a questionary after at least 3 months of therapy

end of 1:1-Block primary endpoint
start of 1:1-Block secondary endpoint

Secondary Outcome

By use of a questionary patients will be asked about side-effects that maybe in relation to the therapy.

end of 1:1-Block secondary endpoint
start of 1:n-Block recruitment countries

Countries of Recruitment

  •   Germany
end of 1:n-Block recruitment countries
start of 1:n-Block recruitment locations

Locations of Recruitment

  • University Medical Center 
  • University Medical Center 
end of 1:n-Block recruitment locations
start of 1:1-Block recruitment

Recruitment

  •   Planned
  •   2012/03/01
  •   35
  •   Multicenter trial
  •   National
end of 1:1-Block recruitment
start of 1:1-Block inclusion criteria

Inclusion Criteria

  •   Both, male and female
  •   14   Years
  •   no maximum age
end of 1:1-Block inclusion criteria
start of 1:1-Block inclusion criteria add

Additional Inclusion Criteria

diagnose of PPP

end of 1:1-Block inclusion criteria add
start of 1:1-Block exclusion criteria

Exclusion Criteria

gastritis, gastric ulcera

end of 1:1-Block exclusion criteria
start of 1:n-Block addresses

Addresses

  • start of 1:1-Block address primary-sponsor
    • Dermatologie Universitätsklinikum Mannheim der Universität Heidelberg
    • Mr.  Prof. Dr. med.  Stefan W.  Schneider 
    • Theodor-Kutzer-Ufer 1-3
    • 68167  Mannheim
    • Germany
    end of 1:1-Block address primary-sponsor
    start of 1:1-Block address contact primary-sponsor
    end of 1:1-Block address contact primary-sponsor
  • start of 1:1-Block address scientific-contact
    • Dermatologie Universitätsklinikum Mannheim der Universität Heidelberg
    • Mr.  Prof. Dr. med.  Stefan W.  Schneider 
    • Theodor-Kutzer-Ufer 1-3
    • 68167  Mannheim
    • Germany
    end of 1:1-Block address scientific-contact
    start of 1:1-Block address contact scientific-contact
    end of 1:1-Block address contact scientific-contact
  • start of 1:1-Block address public-contact
    • Dermatologie Universitätsklinikum Mannheim der Universität Heidelberg
    • Mr.  Prof. Dr. med.  Stefan W.  Schneider 
    • Theodor-Kutzer-Ufer 1-3
    • 68167  Mannheim
    • Germany
    end of 1:1-Block address public-contact
    start of 1:1-Block address contact public-contact
    end of 1:1-Block address contact public-contact
end of 1:n-Block addresses
start of 1:n-Block material support

Sources of Monetary or Material Support

  • start of 1:1-Block address materialSupport
    • Dermatologie Universitätsklinikum Mannheim der Universität Heidelberg
    • Mr.  Prof. Dr. med.  Stefan W.  Schneider 
    • Theodor-Kutzer-Ufer 1-3
    • 68167  Mannheim
    • Germany
    end of 1:1-Block address materialSupport
    start of 1:1-Block address contact materialSupport
    end of 1:1-Block address contact materialSupport
end of 1:n-Block material support
start of 1:1-Block state

Status

  •   Recruiting planned
  •   [---]*
end of 1:1-Block state
start of 1:n-Block publications

Trial Publications, Results and other Documents

  • [---]*
end of 1:n-Block publications
* This entry means the parameter is not applicable or has not been set.